GLP-1 RAs induce an increase in heart rate (HR), which, theoretically, represents a safety concern, as this is considered to be associated with higher cardiovascular risk [13, 14]
2 The triumvirate has expanded in recent years to include additional pathophysiologic defects at play in people with T2D
When compared against the average risk score for a diabetic member, diabetic members not taking GLP-1s are riskier than average, while those taking GLP-1s were less risky than averageand, by a wider margin
Semaglutide is not a miracle cure or a gimmicky fat-burning supplement
I feel like we have other options with more evidence, such as cough lozenges and saline nasal spray
Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC